HF Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
4,322
+155
+4% +$36.1K 0.34% 96
2026
Q1
$1.02M Sell
4,167
-431
-9% -$100K 0.35% 93
2025
Q4
$951K Sell
4,598
-302
-6% -$59.7K 0.33% 99
2025
Q3
$909K Sell
4,900
-122
-2% -$20.9K 0.33% 98
2025
Q2
$767K Sell
5,022
-92
-2% -$14.1K 0.3% 104
2025
Q1
$848K Buy
5,114
+242
+5% +$37.9K 0.37% 101
2024
Q4
$705K Sell
4,872
-152
-3% -$23.6K 0.32% 103
2024
Q3
$814K Sell
5,024
-157
-3% -$25K 0.38% 96
2024
Q2
$757K Buy
5,181
+374
+8% +$55.6K 0.39% 94
2024
Q1
$761K Buy
4,807
+252
+6% +$40.1K 0.43% 86
2023
Q4
$714K Sell
4,555
-9,549
-68% -$1.46M 0.46% 80
2023
Q3
$2.19M Sell
14,104
-553
-4% -$91.3K 1.63% 12
2023
Q2
$2.43M Buy
14,657
+1,642
+13% +$265K 1.92% 8
2023
Q1
$2.02M Buy
13,015
+2,531
+24% +$409K 1.79% 11
2022
Q4
$1.85M Buy
+10,484
New +$1.81M 1.87% 10

Other funds holding JNJ

HF Advisory Group's JNJ Position: Q2 2026 in Review

HF Advisory Group increased its Johnson & Johnson (JNJ) stake by 3.7% in Q2 2026, buying an estimated $36.1K and bringing the position to 4,322 shares worth $1.1M. The position accounts for 0.34% of the portfolio, ranked #96.

HF Advisory Group first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.43M in Q2 2023. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • HF Advisory Group held 4,322 shares of Johnson & Johnson worth $1.1M as of Q2 2026.
  • HF Advisory Group bought 155 Johnson & Johnson shares in Q2 2026, an estimated $36.1K.
  • Johnson & Johnson made up 0.34% of HF Advisory Group's portfolio in Q2 2026, its #96 holding.
  • HF Advisory Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • HF Advisory Group's Johnson & Johnson position peaked at $2.43M in Q2 2023.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.